The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers

Colloids and Surfaces B: Biointerfaces

Volumn 89, Issue 1, 2012, Pages 29-39

  Kaialy, Waseem ^a,b   Martin, Gary P ^c   Larhrib, Hassan ^d   Ticehurst, Martyn D ^e   Kolosionek, Ewa ^a   Nokhodchi, Ali ^a,f  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carrier; Dry powder inhaler; Inhalation efficiency; Lactose crystallisation; Morphology; Non solvent

Indexed keywords

ADHESION FORCES; AERODYNAMIC DIAMETERS; BINARY COMBINATIONS; CARRIER; DRUG CONTENT; DRY POWDER INHALER; FINE PARTICLES; FLOWABILITY; INHALATION EFFICIENCY; MODEL DRUGS; NON-SOLVENTS; PHYSICOCHEMICAL PROPERTY; SALBUTAMOL; SULPHATES; TAP DENSITY; TRUE DENSITY;

ACETONE; AERODYNAMICS; ALCOHOLS; BINARY MIXTURES; CRYSTALLIZATION; MORPHOLOGY;

SUGARS;

LACTOSE; SALBUTAMOL SULFATE;

ARTICLE; BULK DENSITY; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DOSAGE FORM COMPARISON; DRUG STRUCTURE; DRY DEPOSITION; FLOW MEASUREMENT; IMAGE ANALYSIS; IN VITRO STUDY; MOLECULAR WEIGHT; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER INHALER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; SURFACE PROPERTY;

ALBUTEROL; BRONCHODILATOR AGENTS; CRYSTALLIZATION; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES;

EID: 80054988878     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.08.019     Document Type: Article

References (67)

1. Bronsky E., Bucholtz G.A. J. Allergy Clin. Immunol. 1987, 79:741.
2. Timsina M.P., Martin G.P., Marriott C., Ganderton D., Yainneskis M. Int. J. Pharm. 1994, 101:1.
3. Dalby R.N., Tiano S.L., Hickey A.J. Lung Biology Health Disease 1996, vol. 94. p. 441.
4. Smith I.J., Parry-Billings M. Pulm. Pharmacol. Ther. 2003, 16:79.
5. Newman S.P., Busse W.W. Respir. Med. 2002, 96:293.
6. Frijlink H.W., De Boer A.H. Dry powder inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 2004, 1:67-86.
7. Ashurst I., Malton A., Prime D., Sumby B. Pharm. Sci. Technol. Today 2000, 3:246.
8. Patton J.S., Bukar J., Nagarajan S. Adv. Drug Deliv. Rev. 1999, 35:235.
9. Chan H.K. J. Aerosol Med. 2006, 19:21.
10. Young P.M., Traini D., Coates M., Chan H.K. Phys. B: Condens. Matter 2007, 394:315.
11. Kaialy W., Martin G.P., Ticehurst M.D., Momin M.N., Nokhodchi A. Int. J. Pharm. 2010, 392:178.
12. Ganderton D. J. Biopharm. Sci. 1992, 3:101.
13. Guenette E., Barrett A., Kraus D., Brody R., Harding L., Magee G. Int. J. Pharm. 2009, 380:80-88.
14. Steckel H., Müller B.W. Int. J. Pharm. 1997, 154:31.
15. Maa Y.F., Prestrelski S.J. Curr. Pharm. Biotechnol. 2000, 1:283.
16. Chan H.K. Expert Opin. Ther. Patents 2003, 13:1333.
17. Schiavone H., Palakodaty S., Clark A., York P., Tzannis S.T. Int. J. Pharm. 2004, 281:55.
18. Larhrib H., Martin G.P., Prime D., Marriott C. Eur. J. Pharm. Biopharm. 2003, 19:211.
19. Zanen P., Go L.T., Lammers J.W.J. Br. Med. J. 1996, 51:977.
20. Zanen P., Go L.T., Lammers J.W.J. Int. J. Pharm. 1995, 114:111.
21. Zanen P., Go L.T., Lammers J.W.J. Int. J. Pharm. 1994, 107:211.
22. Usmani O.S., Biddiscombe M.F., Nightingale J.A., Underwood S.R., Barnes P.J. J. Appl. Physiol. 2003, 95:2106.
23. Elversson J., Millqvist-Fureby A., Alderborn G., Elofsson U. J. Pharm. Sci. 2003, 92:900.
24. Rasenack N. Pharm. Dev. Technol. 2004, 9:1.
25. Prime D., Atkins P.J., Slater A., Sumby B. Adv. Drug Deliv. Rev. 1997, 26:51.
26. Hinds W.C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles 1999, John Wiley & Sons, Inc., New York, p. 3.
27. Ahfat N.M., Buckton G., Burrows R., Ticehurst M.D. Int. J. Pharm. 1997, 156:89.
28. Buckton G. Adv. Drug Deliv. Rev. 1997, 26:17.
29. Berard V., Lesniewska E., Andres C., Pertuy D., Laroche C., Pourcelot Y. Int. J. Pharm. 2002, 232:213.
30. Jones M.D., Harris H., Hooton J.C., Shur J., King G.S., Mathoulin C.A., Nichol K., Smith T., Dawson M.L., Ferrie A.R., Price R. Eur. J. Pharm. Biopharm. 2008, 69:496.
31. Larhrib H., Martin G.P., Marriott C., Prime D. Int. J. Pharm. 2003, 257:283.
32. Kaialy W., Martin G.P., Ticehurst M.D., Royall P., Mohammad M.A., Murphy J., Nokhodchi A. AAPS J. 2011, 13:30.
33. Kaialy W., Ticehurst M.D., Murphy J., Nokhodchi A. J. Pharm. Sci. 2011, 100:2665.
34. Steckel H., Borowski M., Eskandar F., Villax P. Pharm. Technol. Eur. 2004, 16:2.
35. Dhumal R.S., Biradar S.V., Paradkar A.R., York P. Pharm. Res. 2008, 25:2835.
36. Dickhoff B.H.J., de Boer A.H., Lambregts D., Frijlink H.W. Int. J. Pharm. 2006, 327:17.
37. V. Janoo, Special Report 98-1, US Army Corps of Engineers, Cold Regions Research & Engineering Laboratory, 1998.
38. USP Pharmacopeia, The official compendia of standards, USP 26/NF 21; United States Pharmacopeia Convention, Inc., Rockville, MD, Aerosols, 601, 2003, p. 2114.
39. Nakate T., Yoshida H., Ohike A., Tokunaga Y., Ibuki R., Kawashima Y. J. Control. Release 2004, 97:19.
40. Hino T., Serigano T., Yamamoto H., Takeuchi H., Niwa T., Kawashima Y. Int. J. Pharm. 1998, 168:59.
41. Fiegel J., Garcia-Contreras L., Thomas M., VerBerkmoes J., Elbert K., Hickey A., Edwards D. Pharm. Res. 2008, 25:805.
42. Hassan M.S., Lau R.W.M. AAPS PharmSciTech 2009, 10:1252.
43. Velaga S.P., Bergh S., Carlfors J. Eur. J. Pharm. Sci. 2004, 21:501.
44. Dhumal R.S., Biradar S.V., Paradkar A.R., York P. Int. J. Pharm. 2009, 368:129.
45. Young P.M., Edge S., Traini D., Jones M.D., Price R., El-Sabawi D., Urry C., Smith C. Int. J. Pharm. 2005, 296:26.
46. Sethuraman V.V., Hickey A.J. AAPS Pharm. Sci. Tech. 2002, 3:7.
47. Tinke A.P., Carnicer A., Govoreanu R., Scheltjens G., Lauwerysen L., Mertens N., Vanhoutte K., Brewster M.E. Powder Technol. 2008, 186:154.
48. Raghavan S.L., Ristic R.I., Sheen D.B., Sherwood J.N., Trowbridge L., York P. J. Phys. Chem. B: Condens. Phase 2000, 104:12256.
49. Iida K., Hayakawa Y., Okamoto H., Danjo K., Leuenberger H. Chem. Pharm. Bull. 2001, 49:1326.
50. Tsukada M., Irie R., Yonemochi Y., Noda R., Kamiya H., Watanabe W., Kauppinen E.I. Powder Technol. 2004, 141:262.
51. Podczeck F. Aerosol Sci. Technol. 1999, 31:301.
52. Berlin E., Kliman P.G., Anderson B.A., Pallansch M.J. Thermochim. Acta 1971, 2:143.
53. Lowell S. Characterization of Porous Solids and Powders: Surface Area, Pore size, and Density 2004, Springer, p. 326.
54. Grzesiak A.L., Lang M., Kim K., Matzger A.J. J. Pharm. Sci. 2003, 92:2260.
55. Iida K., Leuenberger H., Fueg L.M., Müller-Walz R., Okamoto H., Danjo K. Yakugaku zasshi: J. Pharm. Soc. Jpn. 2000, 120:113.
56. Louey M.D., Van Oort M., Hickey A.J. Pharm. Res. 2004, 21:1207.
57. Van Campen L., Venthoye G. Inhalation, dry powder. Encyclopedia of Pharmaceutical Technology 2002, Marcel Dekker Inc., New York, p. 1529. 2nd ed.
58. Kaialy W., Momin M.N., Ticehurst M.D., Murphy J., Nokhodchi A. Colloids Surf. B: Biointerfaces 2010, 79:345.
59. Braun M.A., Oschmann R., Schmidt P. Int. J. Pharm. 1996, 135:53.
60. Jones M.D., Price R. Pharm. Res. 2006, 23:1665.
61. Cline D., Dalby R. Pharm. Res. 2002, 19:1274.
62. Bosquillon C., Lombry C., Preat V., Vanbever R. J. Pharm. Sci. 2001, 90:2032.
63. Gupta P.K., Hung C.T., Lam F.C. J. Microencapsul. 1989, 6:147.
64. Wang Y.M., Sato H., Adachi I., Horikoshi I. J. Pharm. Sci. 1996, 85:1204.
65. Hassan E.E., Parish R.C., Gallo J.M. Pharm. Res. 1992, 9:390.
66. Stahlhofen W., Gebhart J., Heyder J. Am. Ind. Hyg. Assoc. J. 1980, 41:385.
67. Mitchell J.P., Nagel M.W. J. Aerosol Med. 2003, 16:341.